Recommended Talks:

Germinal Center Dynamics and HIV Vaccines
September 2015
Moderator
Yegor Voronin, Global HIV Vaccine Enterprise
Introduction
Angela Malaspina, Division of AIDS, NIAID, NIH
Inducing broadly neutralizing antibodies
Bart Haynes, Duke Human Vaccine Institute
Before, during, and after the germinal center reaction
Michael McHeyzer-Williams, The Scripps Research Institute
The role of TFh cells in B cell response
Shane Crotty, La Jolla Institute for Allergy and Immunology
Panelist
Bart Haynes, Duke Human Vaccine Institute
Michael McHeyzer-Williams, The Scripps Research Institute
Shane Crotty, La Jolla Institute for Allergy and Immunology
Garnett Kelsoe, Duke University School of Medicine
Nucleic Acid Delivery Devices for HIV Vaccines
Getting macromolecules into the skin – what works?
May 2015
Ajay Banga, Mercer University
Nucleic Acid Delivery Devices for HIV Vaccines
Delivering your NA vaccine without a needle
May 2015
Dan Williamson, Bioject
eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines
Individualized profiling of germline antibody V genes
March 2017
Gunilla Karlsson Hedestam, Karolinska Institutet
eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines
Antiretroviral treatment of acute HIV infection and the prospect for a functional cure
March 2017
Thumbi Ndung'u, University of KwaZulu-Natal

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 3 day meeting   |   October 2015
A webcast featuring several of the presentations of the 2015 Cent Gardes meeting, addressing a range of topics pertinent to HIV vaccine research. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2015
Immunologists and HIV vaccine experts review recent developments in germinal center (GC) biology and evaluate implications of defective GC physiology. Webcasts | Learn More
Meeting Format: 2 hour meeting   |   July 2015
An interactive session at IAS 2015 to explore the rapidly evolving HIV vaccine field, ranging from vaccine design to development and testing. Webcasts | Learn More
Meeting Format: 2 day meeting   |   June 2015
An exchange of information and experiences and a status update of ongoing efforts related to the GMP manufacturing of HIV ENV proteins. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   May 2015
A focus on immunogens design, novel immunization regimens, and tracking of antibody responses with the goal of eliciting broadly neutralizing antibodies. Webcasts | Learn More
Meeting Format: 1 day meeting   |   May 2015
Review the landscape of past, current and future nucleic acid delivery technologies and learn from the experience of representative clinical trials. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   September 2014
Review the potential roles of the complement system in modulating humoral immunity and discuss the potential to advance the field in a new direction. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   November 2013
A consultation to help determine the intersection between therapeutic and preventive vaccines and to provide recommendations for future developments. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2013
Immunologists and vaccine developers from industry, academia, and government agencies address the challenges of developing a durable HIV vaccine. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   May 2013
A review of current research efforts and remaining gaps and needs in addressing Vaccine-Induced Sero-Positivity/Sero-Reactivity. Webcasts | Learn More
1 2